1Estlin EJ,Ronghe M,Burke GA,et al.The clinical and cellular ph-armacology of vincristine,corticosteroids,L-ASParaginase,anthrac-yclines and cyclophosphamide in relation to childhood acute lymphoblastic leukemia[J].Br J Haematol,2000,110(4):780-790.
2Howard SC,Pui CH.Endocrine complications in pediatric pat-ients with acute lymphoblastic leukemia[J].Blood Rev,2002,16(4):225-243.
3Wacker P, Land V J, Camitta BM, et al. Allergic Reactions to E. coli L-Asparaginase Do Not Affect Outcome in Childhood B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group Study [J]. J Pediatr Hematol Oncol, 2007, 29 (9) :627
4Wetzler M, Sanford BL, Kurtzberg J, et al. Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511[J]. Blood, 2007, 109 (10) :4164
5Top PC, Tissing WJ, Kuiper JW, et al. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage[ J]. Pediatr Blood Cancer, 2005,44 ( 1 ) :95
6Muller HJ, Beier R, Eoning L, et al. Pharmacokinetics of native Escherichiacoli Aspaaraginase( Asparaginase medac) and hypersensitivity reactions in ALL- BFM 95 reinduction treatment[ J]. Br J Haematol, 2001,114 : 794
7Zakarija A, Kwaan HC. Adverse effects on hemostatic function of drugs used in hematologic malignancies [ J ]. Semin Thromb Hemost, 2007,33 (4) :355
8Ruud E, Holmstrom H, de Lange C, et al. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000) : a single-institution study[ J]. Pediatr Hematol Oncol, 2006, 23 (3) :207
9Alves C, Chaves C, Souza M. Transient diabetes mellitus related to L-asparaginase therapy[J]. Arq Bras Endocrinol Metabol. 2007, 51 (4) :635
10Kieslich M, Porto L, Lanfermann H, et al. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia[J]. J Pediatr Hematol Oncol, 2003, 25 (6) : 484
